These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 4356685)

  • 21. The influence of the indigenous bacterial flora upon the interferon response of mice.
    Havell EA; Holtermann OA; Starr TJ
    J Gen Virol; 1970 Oct; 9(1):93-5. PubMed ID: 4991744
    [No Abstract]   [Full Text] [Related]  

  • 22. Multiplication of virulent and avirulent strains of Newcastle disease virus and interferon production in susceptible animals.
    Solovyov VD; Mentkevich LM; Orlova TG; Tatarinova YN
    Acta Virol; 1966 Mar; 10(2):104-10. PubMed ID: 4380453
    [No Abstract]   [Full Text] [Related]  

  • 23. Lower production of circulating interferon in congenitally athymic (nude) mice induced by intravenous administration of Newcastle disease virus.
    Yokota Y; Kishida T; Esaki K; Kawamata J
    Biken J; 1975 Dec; 18(4):275-6. PubMed ID: 1218077
    [No Abstract]   [Full Text] [Related]  

  • 24. Relative absence of circulating antigen-reactive cells during oral immunization.
    Goldberg SS; Kraft SC; Peterson RD; Rothberg RM
    J Immunol; 1971 Sep; 107(3):757-65. PubMed ID: 5106410
    [No Abstract]   [Full Text] [Related]  

  • 25. [Molecular weight of serum interferon induced by the Newcastle disease virus in high and low producer mice].
    Bailey MD; De Maeyer-Guignard J
    Ann Inst Pasteur (Paris); 1972 Dec; 123(6):835-48. PubMed ID: 4676284
    [No Abstract]   [Full Text] [Related]  

  • 26. [Studies of oral immunization. The secondary immune response following primary oral and subsequent oral or parenteral application of bovine serum albumin (BSA) in rabbits].
    Lefèvre H; Uecker W; Blümel P; Raettig H
    Zentralbl Bakteriol Orig; 1970 May; 213(4):548-66. PubMed ID: 4989491
    [No Abstract]   [Full Text] [Related]  

  • 27. The lymphatic route. VI. Distribution of recombinant interferon-alpha 2 in rabbit and pig plasma and lymph.
    Bocci V; Pessina GP; Paulesu L; Nicoletti C
    J Biol Response Mod; 1988 Aug; 7(4):390-400. PubMed ID: 3171601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Production and purification of human leukocyte interferon.
    Matsuo A; Hayashi S; Kishida T
    Jpn J Microbiol; 1974 Jan; 18(1):21-7. PubMed ID: 4546893
    [No Abstract]   [Full Text] [Related]  

  • 29. Tissue distribution of human interferons after exogenous administration in rabbits, monkeys, and mice.
    Billiau A; Heremans H; Ververken D; van Damme J; Carton H; de Somer P
    Arch Virol; 1981; 68(1):19-25. PubMed ID: 6166278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation and characterization of rabbit interferon.
    Ho M; Breinig MC
    Methods Enzymol; 1981; 78(Pt A):131-8. PubMed ID: 6173577
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison between circulating interferon and drug levels following administration of 2-amino-5-bromo-6-phenyl-4(3H)-pyrimidinone (ABPP) to different animal species.
    Hamilton RD; Wynalda MA; Fitzpatrick FA; Teagarden DL; Hamdy AH; Snider BG; Weed SD; Stringfellow DA
    J Interferon Res; 1982; 2(3):317-27. PubMed ID: 6182250
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of interferon by human leukocytes in vitro.
    Strander H; Cantell K
    Ann Med Exp Biol Fenn; 1966; 44(2):265-73. PubMed ID: 4290664
    [No Abstract]   [Full Text] [Related]  

  • 33. Further studies on the production of interferon by human leukocyte in vitro.
    Strander H; Cantell K
    Ann Med Exp Biol Fenn; 1967; 45(1):20-9. PubMed ID: 4294634
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparative study on the interferon production by the leukocytes of healthy and leukaemic subjects.
    Hadházy G; Gergely L; Tóth FD; Szegedi G
    Acta Microbiol Acad Sci Hung; 1967; 14(4):391-7. PubMed ID: 4300286
    [No Abstract]   [Full Text] [Related]  

  • 35. [Attempt at purification of interferon from chickens with the goal of obtaining specific antibodies].
    German A; Quéro AM; Poindron P
    Ann Pharm Fr; 1969 Feb; 27(2):103-13. PubMed ID: 5399802
    [No Abstract]   [Full Text] [Related]  

  • 36. Characteristics of immune interferon produced by human lymphocyte cultures compared to other human interferons.
    Valle MJ; Jordan GW; Haahr S; Merigan TC
    J Immunol; 1975 Jul; 115(1):230-3. PubMed ID: 239056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Gel chromatography of virus-induced interferon from exudate granulocytes].
    Hellmann W; Kohlhage H
    Arch Gesamte Virusforsch; 1973; 40(1):128-31. PubMed ID: 4692623
    [No Abstract]   [Full Text] [Related]  

  • 38. [Physico-chemical characterization of serum interferon of the rabbit after induction by myxoviruses].
    Kohlhage H; Quast R
    Zentralbl Bakteriol Orig; 1970; 212(2):5-81. PubMed ID: 5462802
    [No Abstract]   [Full Text] [Related]  

  • 39. Protection of chickens against Marek's disease virus JM-V strain with statolon and exogenous interferon.
    Vengris VE; Maré CJ
    Avian Dis; 1973; 17(4):758-67. PubMed ID: 4358305
    [No Abstract]   [Full Text] [Related]  

  • 40. Comparison of interferon production in vitro by leukocytes from healthy and polycythaemic persons.
    Hadházy G; Gergely L; Nagy G; Tóth FD
    Acta Microbiol Acad Sci Hung; 1968; 15(2):141-4. PubMed ID: 4300534
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.